Our Annual Report outlines our performance over the past year and our ambitions for the year ahead.
-
Message from the CEO
Marc Vandelaer unveils IBBL's major developments in 2016, as well as the challenges ahead.
-
Beyond borders
With 68 projects, IBBL remained a central biobanking infrastructure at the heart of Europe.
-
Dedication to quality
IBBL's successfully pursued its strategy to provide bioservices of high quality.
-
More than a traditional biobank
IBBL’s various in-house research projects led to 21 scientific publications.
-
Out of the lab into the real world
IBBL had use of multi-support resources to make biobanking more approachable and visible.
-
Together for research in Luxembourg
IBBL worked hand in hand with national partners to advance research in personalised medicine.